Following RA treatment, CRABP2 accumulate in the cytoplasm of GBM cells, blocking the action of RA and activating anti-apoptotic pathway proteins (Cyclin E/CDK2, CRYAB, GFAP, and FABP7). The gene discussed is GFAP; the disease is glioblastoma.